Risk of ovarian failure and fertility preserving methods in girls and adolescents with a malignant disease

BJOG. 2010 Jan;117(2):163-74. doi: 10.1111/j.1471-0528.2009.02408.x.

Abstract

Girls and young women suffering from a malignant disease that requires treatment with chemo- and/or radiotherapy are at risk of losing fertility. The most significant risk factors are age and type of treatment given. Preserving fertility is of high priority to both the young patient and her parents. This article reviews the effect of chemo- and radiotherapy on gonadal function, and thus fertility, and offers different fertility preserving methods based on the literature. Cryopreservation of ovarian tissue is a possible way of preserving fertility in this group of patients in the future.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Antineoplastic Agents, Alkylating / adverse effects
  • Child
  • Cryopreservation*
  • Denmark
  • Female
  • Fertility / drug effects
  • Fertility / radiation effects
  • Fertilization in Vitro
  • Humans
  • Infant
  • Infertility, Female / etiology
  • Infertility, Female / prevention & control
  • Infertility, Female / therapy*
  • Male
  • Menarche / drug effects
  • Menarche / radiation effects
  • Neoplasms / therapy
  • Oocyte Retrieval / methods
  • Oocytes / growth & development
  • Oocytes / transplantation
  • Organ Preservation / methods*
  • Ovarian Follicle / drug effects
  • Ovarian Follicle / radiation effects
  • Pregnancy
  • Primary Ovarian Insufficiency / etiology*
  • Primary Ovarian Insufficiency / therapy
  • Puberty / drug effects
  • Puberty / radiation effects
  • Radiation Injuries / complications
  • Radiation Injuries / prevention & control
  • Survivors / statistics & numerical data
  • Young Adult

Substances

  • Antineoplastic Agents, Alkylating